Trasplante cardiaco como tratamiento del shock cardiogénico: ¿una estrategia eficiente o una «excepción española»?
Francisco José Hernández-Pérez(Marqués de Valdecilla University Hospital), Javier Segovia(Clinica Universidad de Navarra), Mercedes Rivas‐Lasarte(Universitat Autònoma de Barcelona), Cristina Mitroi(Hospital Universitario Puerta de Hierro Majadahonda), Manuel Gómez‐Bueno(Hospital Universitario Puerta de Hierro Majadahonda), Alba Martín‐Centellas
Cited by 2
Related Papers
COVID-19 in transplant recipients: The Spanish experience
|American Journal of Transplantation|2020|200
Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients for Primary Prevention
|Circulation Arrhythmia and Electrophysiology|2011|152
Usefulness of Two-Dimensional Strain Parameters to Diagnose Acute Rejection after Heart Transplantation
|Journal of the American Society of Echocardiography|2015|128
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations
|Revista Española de Cardiología (English Edition)|2017|112
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
|Annals of Intensive Care|2017|89